Literature DB >> 10679715

Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis.

A Inukai1, S Kuru, Y Liang, A Takano, Y Kobayashi, M Sakai, M Doyu, G Sobue.   

Abstract

Polymyositis (PM) is an autoimmune inflammatory muscle disease of unknown cause in which cellular immunity is thought to play an important pathogenic role. Class II major histocompatibility complex (class II MHC: human leukocyte antigen (HLA)-DR operates as a cofactor of antigen presentation in immunological responses. There has been a major debate over whether muscle fibers themselves synthesize and express HLA-DR molecules and play a role in antigen presentation in PM pathogenesis. In this study, we demonstrated that most muscle fibers from patients with PM synthesized and expressed HLA-DR molecules on their surface. Human leukocyte antigen-DR expression was highly specific to PM. In addition, class II transactivator (CIITA), human leukocyte antigen DM (HLA-DM), and invariant chain (Ii), which are indispensable for expression of mature HLA-DR molecules and for antigen processing and presentation, were co-expressed. One of the cytokines that could induce this expression is interferon-gamma (IFN-gamma), released by activated lymphocytes. Our results indicate that in PM muscle fibers synthesize and express HLA-DR molecules and may contribute to the inflammatory responses together with lymphocytes. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679715     DOI: 10.1002/(sici)1097-4598(200003)23:3<385::aid-mus10>3.0.co;2-t

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

1.  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

Authors:  C Dorph; P Englund; I Nennesmo; I E Lundberg
Journal:  Ann Rheum Dis       Date:  2006-07-10       Impact factor: 19.103

2.  Clinicopathological features of sarcoidosis manifesting as generalized chronic myopathy.

Authors:  Shinya Maeshima; Haruki Koike; Seiya Noda; Tomoko Noda; Hirotaka Nakanishi; Masahiro Iijima; Mizuki Ito; Seigo Kimura; Gen Sobue
Journal:  J Neurol       Date:  2015-02-26       Impact factor: 4.849

3.  Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.

Authors:  P Englund; E Lindroos; I Nennesmo; L Klareskog; I E Lundberg
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 4.  Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature.

Authors:  Hui-Jung Kim; Yun-Kyung Hong; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2008-12-18       Impact factor: 2.631

5.  Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.

Authors:  Jessie Aouizerate; Marie De Antonio; Guillaume Bassez; Romain K Gherardi; Francis Berenbaum; Loïc Guillevin; Alice Berezne; Dominique Valeyre; Thierry Maisonobe; Odile Dubourg; Anne Cosnes; Olivier Benveniste; François Jérôme Authier
Journal:  Acta Neuropathol Commun       Date:  2014-10-23       Impact factor: 7.801

6.  Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection.

Authors:  Tomoyuki Uchiyama; Kimito Arai; Takako Yamamoto-Tabata; Kanji Hirai; Kouji Kishimoto; Yoshiko Nakamura; Takamichi Hattori
Journal:  J Neurol       Date:  2005-03-04       Impact factor: 6.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.